Quantitative analysis for MiniMed Group, Inc. Common Stock (MMED) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Strong Buy (84.0) (grade A). 31 signals analyzed (25 differentiated alt-data).
MMED stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $13.39 | $12.69 | $12.94 |
| 2026-05-08 | $12.08 | $11.25 | $11.57 |
| 2026-05-20 | $11.68 | $10.75 | $11.63 |
| 2026-06-02 | $12.45 | $11.46 | $12.30 |
| 2026-06-12 | $15.68 | $15.00 | $15.16 |
| 2026-06-25 | $14.76 | $13.94 | $14.22 |
| 2026-07-08 | $15.51 | $14.76 | $15.02 |
| 2026-07-20 | $17.33 | $16.80 | $16.92 |
| 2026-07-30 | $18.66 | $18.10 | $18.15 |
| 2026-08-12 | $20.72 | $19.40 | $20.70 |
| 2026-08-24 | $20.68 | $19.63 | $19.94 |
| 2026-09-03 | $24.16 | $23.19 | $23.84 |
How MiniMed Group, Inc. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| BLLN | BillionToOne, Inc. | $3.8B | — |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | $4.1B | — |
| KLRA | Kailera Therapeutics, Inc. | $2.6B | — |
| NAMS | NewAmsterdam Pharma Company N.V. | $4.2B | — |
View all Health Care stocks by valuation and signals →
MiniMed Group, Inc. Common Stock (MMED) scores Strong Buy (84.0), and the composite conceals a 43-point disagreement between its dimensions. It is strongest on social sentiment at 71 and technicals at 62, and weakest on competitive moat at 35 and analyst consensus at 28. A stock can carry social sentiment that high while analyst consensus sits at 28; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| social sentiment | 71 |
| technicals | 62 |
| competitive moat | 35 |
| analyst consensus | 28 |
StoQuant analyzes 31 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on MiniMed Group, Inc. Common Stock (MMED): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/MMED"><img src="https://stoquant.com/badge/MMED.svg" alt="MiniMed Group, Inc. Common Stock (MMED) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.